241 related articles for article (PubMed ID: 18668589)
1. An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4+CD25+ cells.
Härle P; Pongratz G; Albrecht J; Tarner IH; Straub RH
Arthritis Rheum; 2008 Aug; 58(8):2347-55. PubMed ID: 18668589
[TBL] [Abstract][Full Text] [Related]
2. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
3. The sympathetic nervous system stimulates anti-inflammatory B cells in collagen-type II-induced arthritis.
Pongratz G; Melzer M; Straub RH
Ann Rheum Dis; 2012 Mar; 71(3):432-9. PubMed ID: 21953335
[TBL] [Abstract][Full Text] [Related]
4. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
[TBL] [Abstract][Full Text] [Related]
7. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells.
Frey O; Petrow PK; Gajda M; Siegmund K; Huehn J; Scheffold A; Hamann A; Radbruch A; Bräuer R
Arthritis Res Ther; 2005; 7(2):R291-301. PubMed ID: 15743476
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.
Morgan ME; Flierman R; van Duivenvoorde LM; Witteveen HJ; van Ewijk W; van Laar JM; de Vries RR; Toes RE
Arthritis Rheum; 2005 Jul; 52(7):2212-21. PubMed ID: 15986351
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.
Lee SI; Hyun PM; Kim SH; Kim KS; Lee SK; Kim BS; Maeng PJ; Lim JS
Arthritis Rheum; 2005 Jan; 52(1):345-53. PubMed ID: 15641090
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts.
Ohata J; Miura T; Johnson TA; Hori S; Ziegler SF; Kohsaka H
Arthritis Rheum; 2007 Sep; 56(9):2947-56. PubMed ID: 17763426
[TBL] [Abstract][Full Text] [Related]
11. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
[TBL] [Abstract][Full Text] [Related]
12. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
14. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
[TBL] [Abstract][Full Text] [Related]
15. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
[TBL] [Abstract][Full Text] [Related]
16. CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.
Morgan ME; Witteveen HJ; Sutmuller RP; de Vries RR; Toes RE
Hum Immunol; 2004 Nov; 65(11):1319-27. PubMed ID: 15556682
[TBL] [Abstract][Full Text] [Related]
17. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.
Ju JH; Cho ML; Jhun JY; Park MJ; Oh HJ; Min SY; Cho YG; Hwang SY; Kwok SK; Seo SH; Yoon CH; Park SH; Kim HY
Immunol Lett; 2008 Apr; 117(1):16-25. PubMed ID: 18242716
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
